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The necessity of controlling the lipid state of the organism originates from the 
association of dyslipidemia with atherosclerosis, heart diseases, diabetes mellitus, etc. In 
the clinical practice, the determination of the exact type of dyslipidemia is not 
straightforward due to certain problems: daily biological fluctuations, dietary effects, 
strong overlapping in characteristic plasma lipid levels in some classes of type lib, III 
and IV, frequent inavailability of a complete set of diagnostic measurements, as well as 
certain overlapping in the borderline values. These provide the objective to create a 
computer program for diagnostics* of dyslipidemia in 16 classes. The apparatus of Bayes 
classification has been applied using 13 discrete and 7 pseudo-discrete features. The 
proposed system is suitable for monitoring the treatment of dyslipidemia as well as for 
the purposes of students' education and post doctoral training. 
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Dyslipoproteinemia represents a 
major risk factor for atherosclerosis . 
The specific factors increasing the 
risk for atherosclerosis include, 
elevated serum levels of low-density 
lipoproteins ( L D L ) carrying 
cholesterol from the liver to the 
periferal tissues and low serum levels 
of high-density lipoproteins ( H D L ) 
evacuating the cholesterol from the 
extrahepatic tissues (1). Hypertrigly-
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ceridemia is often regarded as an 
independent risk-factor for 
atherosclerosis especially in diabetes 
mellitus when the lipoprotein 
catabolism is impaired (9). Reduction 
of LDL-cholesterol ( L D L c h ) by 12,6 
% is accompanied by a 2% increase in 
HDL-cholesterol ( H D L c h ) , whereas a 
25 % reduction in the total cholesterol 
( T C ) results in a 50 % decrease in the 
vasular risk (7). Following 5 years of 
adequate diet and drug therapy the 
risk for cardiovascular diseases 
decreases by 34 % in patients with 
primary hyperlipoproteinemia and 
non-HDL c h less than 5,2 mM (6). 
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Modulation of the plasma lipoprotein 
levels by Colestipol® and Ac . 
nicotinici for about 2 years reduces 
L D L by 43 % and increases H D L , 
ch J ch 
by 37 % in patients with coronary 
arterial bypass. These changes are 
accompanied by a significant 
diminution in the number of 
angiographically proved new lesions 
in the arteries and by improvement of 
the whole coronary state (6,7). H D L 
affects some other aspects of 
atherogenesis related to cholesterol 
deposition (e.g.suppression of 
thrombocyte aggregation, stimulation 
of prostacyclin production in the 
arteries) (6,9). In screened males aged 
between 35 and 70 years the relative 
mortality risk from myocardial 
infarction at a T C of 6,5 m M (85 t h 
percentile) is 3,8 - fold higher than at 
T C of 4,7 m M (20 t h percentile). 
According to the Framingham Group 
Study, plasma cholesterol level is 
directly related to the mortality ratio 
in individuals younger than 50 years 
and particularly at the age of about 30 
years (11). Hyperlipidemia is 
established in approximately 40-50 % 
of the diabetics and probably their 
increased morbidity and mortality 
rates of coronary disease are related to 
it (5,10,12-14,17). Triglyceride ( T G ) 
reduction to normal values results in a 
50% lower coronary risk (1,6 instead 
3,0) (10). 
Hypertriglyceridemia represents 
the most essential anomaly of the 
64 
lipid metabolism in diabetes mellitus 
(6,7,15,17). Hyperlipidemia that is 
secondarily determined by some other 
metabolic diseases can persist for a 
long time after the cessation of the 
effective treatment of the primary 
disease. A l l these data indicate the 
necessity of a regular monitoring of 
the lipid state in the general 
population with the objective of early 
diagnosis of dyslipidemia and its 
appropriate treatment . Plasma lipid-
level shows daily biological fluc­
tuations and affected by the diet. That 
is why the diagnosis of dyslipidemia 
should be based on at least two 
complete lipid analyses in the course 
of 2 weeks (6). In order to facilitate 
the evaluation of these disturbances, 
several classifications have been 
created (e.g., Frederickson, Schlierf, 
Kahlke, European Atherosclerosis 
Society, a Therapeutic Classification 
of Hyperlipidemiae, etc.) (1,2,4,6). 
Despite the merit of these 
classifications in the clinical practice 
often patients with lipid disturbances 
could hardly be classified into a 
definite class of dyslipidemia due to 
the overlapping of the lipid value-
ranges for some classes (e.g., type ПЬ, 
Ш, and I V ) . That is the case with 
asymptomatic patients with subcli­
nical atherosclerosis, ischemic heart 
disease, liver steatosis, diabetes 
mellitus type П, initial nephropathy 
(9,10). On the other hand, a few 
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health institutions can afford to 
examine the lipid state as a whole. 
The purpose of the present 
paper is to elaborate a specialised 
algorithm for computer-aided diag­
nostics. 
MATERIAL AND METHODS 
Building of a classifier using 
discrete and pseudo-discrete features 
Lipid profile parameters are 
continuous numbers with diagnostic 
information concentrated in different 
intervals of the numerical axis. They 
are particularly appropriate for 
representation with the so-called 
pseudo-discrete features (16). In 
addition to the lipid profile, 
information about the dyslipidemia 
type is found in external symptoms 
that are typical discrete features. 
Therefore, the diagnostics of 
dyslipidemia can be formulated as a 
problem for classification using 
discrete and pseudo-discrete features. 
The following parameters are 
introduced: w k (k=l,2,.. . ,c), classes of 
state with a priory probabilities 
P ( w k ) ; the random vector of 
observation X consisting of a vector 
with r discrete features and a 
vector X ^ with s pseudo-discrete 
ones. The i-co-ordinate xf of X^ 
adopts one of a number of bj discrete 
values (Хр=1,2, ... j . . . , bj) and its 
value is 0 for unknown xf. The p|j 
denotes the probability Xj to occupy 
j-discrete value, i f the observation x 
belongs to class w k ( x e w k ) . 
Let i-co-ordinate X j P of X ( p ) be 
a continuous random value that has 
typical ranges [ D j j j U j j ] and the 
limits of these ranges are as follows: 
D 1 J < U 1 J < D Z J < U 2 J < . . . < D r > J < U r > J 
Then, either Xj belongs to the 
interval D i \ l U n . j ] , or it is NaN 
meaning an unknown value. The C^kj 
denotes the probability xf to occupy 
j-typical range i f X е W(< and there 
no untypical range exists. Then 
j=l 
The latter condition; enables the 
expert easily to determine these 
probabilities disregarding any atypical 
cases. The following subsiduary 
functions are introduced in order to 
determine the belonging of X j P to j -
typical range: 
0 for xT < U,_M 
(xj' - и м , ) / (D M - U h U ) for UhU < xj' < D M 
< 1 for Dj j < xf < Uj 
( D ( + , , - x j , ) / ( D J + M - U , i ) for и , ( < х | ' < 0 ( + м 
for 
The assumption for an 
independence of the features (8) 
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Table 1 
Names and limits for the typical ranges of 
the pseudc -discretes features 
Feature Range Limits 
(mM) 
normal 0.5-1.7 
T G increased 2.2-5 
extremely increased 10-70 
normal 2-5.2 
T C increased 8-10 
extremely increased 15-70 
decreased 0.1-0.7 
H D L c h normal 0.9-1.3 
increased 1.6-3 
normal 2.5-4.9 
L D L c h increased 5.5-7 
extremely increased 8-20 
V L D L c h normal 0.05-0.3 
increased 0.5-5 
decreased 0-250 
ApoA normal 290-775 
increased 800-2000 
ApoB normal 30-150 
increased 180-800 
(required to avoid "the curse of 
dimensionality") results in a Bayes-
classifier (16): 
A k ( x ) = l n P ( w k ) + Х 1 п р . к х р + 
SlnXqWtxf), 
i=i ' j=i 
where (pj(NcN) = 1 a n d p i 0 = l 
From the so-called 
discriminators A k (for k=l,2,...c) the 
desired a posterior probabilities 
P ( w k / x ) are obtained (8): 
P ( w k / x ) = l / X a [ A j ( " b A k W ] 
j=i 
where "e « 2.7183" is the base 
of the natural logarithms. 
A key component of the 
algorithm is the parameter estimation 
Table 2 
Conditional probabilities for the presence of the discrete symptoms pf i fp^ — 1 ~" pjj) 
Feature 
Class 
1 '2 3 4 5 6 7 8 9 10 11 12 13 
1 0.1 0.7 0.01 0 0 0.01 0.5 0.2 0.2 0 0.2 0.01 0.3 
2 0.3 0.5 0 0.15 0.1 0.4 0.3 0.1 0.05 0.2 0.15 0.05 0.15 
3 0.2 0.7 0.1 0.1 0.1 0.5 0.5 0.4 0.4 0.2 0.2 0.03 0.1 
4 0.7 0.9 0 0.7 0.5 0.9 0.6 0.8 0.9 0.05 0.2 0.05 0.05 
5 0.2 0.8 0.2 0.2 0.15 0.8 0.8 0.6 0.5 0.2 0.3 0.02 0.05 
6 0.9 0.9 0.6 0.6 0.1 0.5 0.8 0.8 0.7 0.6 0.1 0.3 0.05 
7 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
8 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
9 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
10 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
11 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
12 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
13 0,05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
14 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
15 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
16 0.05 0.3 0.02 0.05 0.01 0.1 0.2 0.01 0.01 0.05 0.01 0.005 0 
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Table 3 
Conditional probabilities of the pseudo-discrete features 
Feature 1 2 3 4 5 6 7 
Range 
Class 
1 2 3 1 2 3 1 2 3 1 2 3 1 2 1 2 3 1 2 
1 0 0 1 07 0.3 0 1 0 0 0 1 0 0 1 0.5 0.5 0 0 1 
2 0.6 0.4 0 0 1 0 0.2 0.8 0 0 0.7 0.3 0.5 0.5 0.1 0.9 0 0 1 
3 0 1 0 0.2 0.4 0.4 0.9 0.1 0 0.3 0.3 0.4 0.1 0.9 0.7 0.3 0 0.3 0.7 
4 0 1 0 0.5 0.5 0 0.6 0.4 0 0.4 0.6 0 0 1 0.9 0.1 0 0.5 0.5 
5 0 1 0 0.5 0.5 0 0.5 0.5 0 0.7 0.3 0 0 1 0.75 0.25 0 0.5 0.5 
6 0 0 1 0 1 0 1 0 0 0.4 0.5 0.1 0.3 0.7 0 1 0 0 1 
7 1 0 0 1 0 0 0 1 0 1 0 0 1 0 0 1 0 1 0 
8 1 0 0 1 0 0 0 1 0 0 1 0 1 0 0 1 0 1 0 
9 1 0 0 1 0 0 0 1 0 1 0 0 0 1 0 1 0 1 0 
10 1 0 0 1 0 0 0 1 0 1 0 0 1 0 1 0 0 1 0 
11 1 0 0 1 0 0 0 1 0 1 0 0 1 0 0 0 1 1 0 
12 1 0 0 1 0 0 0 1 0 1 0 0 1 0 0 1 0 0 1 
13 1 0 1 0 0 0 1 0 1 0 0 1 0 0 1 0 1 0 
14 1 0 0 1 0 0 1 0 1 0 0 1 0 0 1 0 1 0 
15 1 0 0 1 0 0 0 0 1 1 0 0 1 0 0 1 0 1 0 
16 1 0 0 1 0 0 1 0 0 1 0 0 1 0 0 1 0 1 0 
of the conditional probabilities к PiJ 
and q f j . Three different approaches 
for their estimation are described in 
(16) and (3): a) by an expert and 
according to literature data; b) from a 
learning sample, consisting of 
examples for a given class (called 
learning observations), and c) by 
pseudo-Bayes estimates combining 
both of the aforementioned 
approaches. In any case, the 
conditional probabilities become 
more and more adequate to the 
problem under consideration with 
information accumulation in the 
course of exploitation of the 
diagnostic system. The process 
described is called learning. The 
relative insensitivity to the input 
inaccuracies is considered to be a 
typical feature of the algorithm 
described. 
RESULTS AND DISCUSSION 
Diagnostics of dyslipidemia 
Based on the above presented 
algorithm a diagnostic system 
classifying in the following classes 
has been elaborated: 
1. type I ; 
2. type Ha; 
3. type l ib; 
4. type I I I ; 
5. type I V ; 
6. type V ; 
7. normal lipid-state; 
8. isolated hyper-LDL-emia; 
9. isolated hyper-VLDL-emia; 
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15. isolated hyper-HDL-emia; 
16. isolated hypo-HDL-emia. 
The computer system makes use 
of 13 discrete features : 
1. hereditary predisposition; 2. 
obesity; 3. xanthomas; 4. Xanthe-
lasms; 5. "cholesterol ring"; 6. 
sclerotic manifestations; 7. diabetes 
mellitus; 8.pancreatitis; 9. liver 
disease; 10. renal failure; 11. gout; 12. 
nephritis; 13. myxoedema, as well as 
of 7 pseudo-discrete ones: 
1. triglycerides ( T G ) ; 2. total 
cholesterol ( T C ) ; 3. H D L ; 4. L D L ; 5. 
very law density lipoproteins 
( V L D L ) ; 6.apoprotein A (ApoA); 7. 
apoprotein В (ApoB). 
A l l the discrete features have 
two discrete values (r=2, i . е., there 
is/there is not). The pseudo-discrete 
features are mainly ternary (s=3), 
however, the fifth and the seventh 
ones are binary (s=2). A l l these 
features can also be unknown during 
recognition. The names and the limits 
of the typical ranges of the pseudo-
discrete features in m M units are 
presented in Table l .The conditional 
probabilities for discrete features are 
given in Table 2 (for the discrete 
value "there is" only), but those for 
the pseudo-discrete ones are shown in 
Table 3. They have been determined 
according to literature data available 
and by expert's interviewing. 
The software was written on 
M A T L A B for Windows 4.2. c . l . 
Simulink and works on P C 486 / 66 
MHz / 8 M B . A possibility exists for 
adaptation of the system to newly 
acquired data and for correction of the 
diagnostic value of the features, in the 
process of recognition and the 
diagnostic value of learning 
observations in the course of learning 
of the procedure. 
The experiments carried out 
with 67 preliminary diagnosed 
patients (containing mainly pseudo-
discrete features) show that the 
system detects the true class in 47 
cases (70 % ) with the greatest a 
posterior probability (the mean value 
of the a posterior probability in case 
of correct classification being 73 % ) . 
The second most probable classes 
have a mean a posterior probability of 
27 % that can serve as an indicator for 
the quality of the classification. In 
cases when the true class is not the 
most probable one, the mean value of 
the a posterior probability is 34 % 
while the classes considered most 
probable have an average probability 
of 49 %. This indicates that the true 
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classification occurs rather often and 
it is performed with a relatively great 
reliability. On the other hand, even in 
the case of error, serious indications 
exist which prevent the ignoring the 
correct class. 
CONCLUSIONS 
The algorithm and the 
developed software-product are useful 
when the complete lipid profile of the 
patient is not available or there are 
uncertainties in defining the 
dyslipidemia type in order to 
prognostisise the atherogenic risk. It 
can also be used to monitor the 
treatment of dyslipidemia 
management. The software is, in our 
opinion, suitable for students' 
education and postdoctoral training. 
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Определяне на дислипидемията с помощта на дискретни и 
псевдодискретни признаци 
К. Тенекеджиев, А. Протопопова*, Ж . Михова 
Катедра по техника и технология за охрана на водите и въздуха, Технически 
университет - Варна и *Катедра по ендокринология, гастроентерология и 
болести на обмяната, Медицински университет - Варна 
Резюме: Необходимостта от контролиране на липидния статус на оргнизма 
произлиза от връзката на дислипидемията с атеросклерозата, сърдечните 
заболявания, захарния диабет и др. В клиничната практика определянето на точния 
тип дислипидемия не е просто поради някои проблеми като напр. ежедневните 
биологични колебания, ефектите на приетата храна, изразеното припокриване на 
характерните нива на плазмените липиди при някои класове от Иб, I I I и IV тип, 
честата недостъпност на пълния комплект за диагностични измервания, както и 
поради известно припокриване на граничните стойности. Тези моменти са в 
основата на поставената цел за създаване на компютърна програма за диагностика 
на дислипидемията, разпределена в 16 класа. Приложен е апаратът на 
класификацията на Байес с използване на 13 дискретни и 7 псевдо-дискретни 
признака. Предложената система е подходяща за мониториране на лечението на 
дислипидемията, както и за целите на образованието на студентите по медицина и 
следдипломната им квалификация. 
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